Searched for
SUN PHARMA USFDA
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- US FDA issues import alert on Sun Pharma's Halol facilitySun Pharma on Thursday said the US Food and Drug Administration (USFDA) has imposed an import alert on its Halol manufacturing site in Guja...
- Sun Pharma shares fall over 3% after USFDA actionShares of Sun Pharmaceutical on Thursday lost up to 3.5% to hit the day's low at Rs 981.50 in morning trade after the company told stock ex...
- Sun Pharma gets USFDA nod for drug to treat neonatal seizures"With this approval, SEZABY becomes the first and only product specifically indicated in the US for the treatment of neonatal seizures in t...
- Aurobindo, Sun Pharma recall products in US marketWhile Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Phar...
- Is Sun Pharma's Halol site close to a rebound?About 40% of the US revenues of Sun Pharmaceutical Industries, India's most valuable pharmaceutical company, is linked to its Halol site.
- Sun Pharma gets 3 observations from USFDA for Halol plantThe United States Food and Drug Administration (USFDA) conducted the Good Manufacturing Practices (GMP) inspection of the company's Halol f...
- Sun Pharma tanks 3% on surprise USFDA visit to Dadra plantThe stock fell 2.69% to hit a low of Rs 668 on BSE.
- USFDA subjects SPARC Xelpros nod to 'satisfactory resolution'Earlier this month, Sun Pharma said the US health regulator had made nine observations after the completion of inspection of its Halol faci...
- USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
- US FDA finds fault in accuracy of test methods at Sun’s Halol siteThe agency also found that scientifically sound and appropriate lab control mechanisms were not established.
- USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
- Sun Pharma surges 3% on Halol unit re-inspectionAs per estimates, the Halol site that produces a range of products from tablets to nasal sprays, contributes over 15% of Sun Pharma's reven...
- SPARC and Sun Pharma ink licensing pact for epilepsy drug"As per the agreement, SPARC will license Elepsia XRTM (Levetiracetam Extended Release tablets) to a wholly-owned subsidiary of Sun Pharma ...
- Expect delay in start of royalty from 2 new drugs: SPARCSun Pharma Advanced Research Company (SPARC) expects further delay in start of royalty income from its two new drug applications, including...
- Sun Pharma's Caraco gets USFDA nod to resume drug productionSun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subs...
- Sun Pharma's US arm resolves issues with health regulatorUSFDA had pulled up the US arm of Sun Pharma for violation of manufacturing standards such lack of consistent quality.
- Sun Pharma’s US arm cuts 350 jobsSun Pharmaceutical’s US subsidiary, Caraco Pharma, has decided to cut its workforce by more than a half after the recent clampdown by USFDA...
Load More
